To review literature regarding the effect of diabetes medications as a contributing risk for falls and fall-related morbidity in elderly patients with type 2 diabetes.
Data sources
Primary literature was identified through PubMed MEDLINE (1966–November 2009) using the search terms elderly, aged, older adults, diabetes type 2, diabetes mellitus, falls, fractures, medication, hypoglycemia, and vitamin B12 deficiency. Each drug class and the individual agents within the classes were also included in the search. Additional references were obtained through review of references from articles obtained.
Study selection and data extraction
Clinical studies evaluating diabetes medications and their association with falls, as well as studies evaluating their association with the complications of falls, were considered for inclusion. Selection emphasis was placed on randomized studies evaluating diabetes medications and falls.
Data synthesis
There is no direct link between metformin and falls; however, an indirect association caused by neuropathy secondary to vitamin B12 deficiency may be of concern. Although hypoglycemia is a risk factor, to date, there are no trials specifically linking insulin secretagogues to falls. Insulin use has been demonstrated to increase the risk of falls in the elderly. Thiazolidinediones increase fracture risk and thus may worsen fall-related outcomes. There are no studies to date linking other agents to an increased risk of falls.
Conclusions
Special considerations should be made when treating elderly patients with diabetes. At this time, a patient's functional level and risk factors for falls should weigh into decision-making regarding drug selection. The risk of falls and fall-related complications associated with diabetes medications should not be ignored.
MaurerM.S., BurchamJ., ChengH.Diabetes mellitus is associated with an increased risk of falls in elderly residents of a long-term care facility.J Gerontol A Biol Sci Med Sci2005; 60: 1157–62.
2.
BrownA.F., MangioneC.M., SalibaD., SarkisianC.A.. Guidelines for improving the care of the older person with diabetes mellitus.J Am Geriatr Soc2003; 51: S265–80.
3.
TinettiM.E., SpeechleyM., GinterS.F.. Risk factors for falls among elderly persons living in the community.N Engl J Med1988; 319: 1701–7.
4.
KingM.B., TinettiM.E.. Falls in community-dwelling older persons.J Am Geriatr Soc1995; 43: 1146–54.
5.
SchwartzA.V., SellmeyerD.E., EnsrudK.E.Older women with diabetes have an increased risk of fracture: a prospective study.J Clin Endocrinol Metab2001; 86: 32–8.
6.
BondsD.E., LarsonJ.C., SchwartzA.V.Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study.J Clin Endocrinol Metab2006; 91: 3404–10.
7.
IversR.Q., CummingR.G., MitchellP., PedutoA.J.. Diabetes and risk of fracture: the Blue Mountains Eye Study.Diabetes Care2001; 24: 1198–203.
8.
AhmedL.A., JoakimsenR.M., BerntsenG.K., FonneboV., SchirmerH.Diabetes mellitus and the risk of non-vertebral fractures: the Tromso study.Osteoporos Int2006; 17: 495–500.
9.
WhitesideG.T., BouletJ.M., SellersR., BuntonT.E., WalkerK.Neuropathy-induced osteopenia in rats is not due to a reduction in weight borne on the affected limb.Bone2006; 38: 387–93.
10.
KatayamaY., AkatsuT., YamamotoM., KugaiN., NagataN.Role of non-enzymatic glycosylation of type I collagen in diabetic osteopenia.J Bone Miner Res1996; 11: 931–7.
11.
MiyataT., NotoyaK., YoshidaK.Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles.J Am Soc Nephrol1997; 8: 260–70.
12.
ZhouZ., ImmelD., XiC.X.Regulation of osteoclast function and bone mass by RAGE.J Exp Med2006; 203: 1067–80.
13.
BoydR., StevensJ.A.. Falls and fear of falling: burden, beliefs and behaviours.Age Ageing2009; 38: 423–8.
14.
Shumway-CookA., CiolM.A., HoffmanJ., DudgeonB.J., YorkstonK., ChanL.Falls in the Medicare population: incidence, associated factors, and impact on health care.Phys Ther2009; 89: 324–32.
15.
MillerR.R., BallewS.H., ShardellM.D.Repeat falls and the recovery of social participation in the year post-hip fracture.Age Ageing2009; 38: 570–5.
16.
SimoneauG.G., UlbrechtJ.S., DerrJ.A., BeckerM.B., CavanaghP.R.. Postural instability in patients with diabetic sensory neuropathy.Diabetes Care1994; 17: 1411–21.
17.
VolpatoS., LeveilleS.G., BlaumC., FriedL.P., GuralnikJ.M.. Risk factors for falls in older disabled women with diabetes: the Women's Health and Aging study.J Gerontol A Biol Sci Med Sci2005; 60: 1539–45.
18.
RichardsonJ.K., HurvitzE.A.. Peripheral neuropathy: a true risk factor for falls.J Gerontol A Biol Sci Med Sci1995; 50: M211–5.
19.
Standards of medical care in diabetes—2009.Diabetes Care2009; 32(suppl 1): S13–61.
20.
StrattonI.M., AdlerA.I., NeilH.A.Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.BMJ2000; 321: 405–12.
21.
AdlerA.I., StrattonL.M., NeilH.A.Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study.BMJ2000; 321: 412–9.
22.
DukasL.C., SchachtE., MazorZ., StahelinH.B.. A new significant and independent risk factor for falls in elderly men and women: a low creatinine clearance of less than 65 ml/min.Osteoporos Int2005; 16: 332–8.
23.
FaulknerK.A., CauleyJ.A., ZmudaJ.M.Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women.Osteoporos Int2006; 17: 1318–28.
24.
GallagherJ.C., RapuriP.B., SmithL.M.. An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment.J Clin Endocrinol Metab2007; 92: 51–8.
25.
Bischoff-FerrariH.A., Dawson-HughesB., WillettW.C.Effect of vitamin D on falls: a meta-analysis.JAMA2004; 291: 1999–2006.
26.
Dawson-HughesB., HarrisS.S., KrallE.A., DallaiG.E.. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older.N Engl J Med1997; 337: 670–6.
27.
SchwartzA.V., VittinghoffE., SellmeyerD.E.Diabetes-related complications, glycemic control, and falls in older adults.Diabetes Care2008; 31: 391–6.
28.
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33).UK Prospective Diabetes Study (UKPDS) Group.Lancet1998; 352: 837–53.
29.
NelsonJ.M., DufrauxK., CookP.F.. The relationship between glycemic control and falls in older adults.J Am Geriatr Soc2007; 55: 2041–4.
30.
NathanD.M., BuseJ.B., DavidsonM.B.Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.Diabetes Care2009; 32: 193–203.
31.
OlmedoC., SacanellaE., MasanesF., FormigaF., Lopez SotoA.Vitamin B12 deficiency: an unusual cause of falls in the elderly.Aging Clin Exp Res2004; 16: 255–6.
32.
TingR.Z., SzetoC.C., ChanM.H., MaK.K., ChowK.M.. Risk factors of vitamin B(12) deficiency in patients receiving metformin.Arch Intern Med2006; 166: 1975–9.
BaumanW.A., ShawS., JayatillekeE., SpungenA.M., HerbertV.Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin.Diabetes Care2000; 23: 1227–31.
35.
FickD.M., CooperJ.W., WadeW.E., WallerJ.L., MacleanJ.R., BeersM.H.. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.Arch Intern Med2003; 163: 2716–24.
36.
Product information.Starlix (nateglinide).East Hanover, NJ: Novartis, July 2008.
37.
Product information.Prandin (repalglinide).Princeton, NJ: Novonordisk, June 2006.
38.
Product information.Glucotrol (glipizide).New York: Pfizer, October 2000.
39.
SchwartzA.V., HillierT.A., SellmeyerD.E.Older women with diabetes have a higher risk of falls: a prospective study.Diabetes Care2002; 25: 1749–54.
40.
LeowM.K., WyckoffJ.Under-recognised paradox of neuropathy from rapid glycaemic control.Postgrad Med J2005; 81: 103–7.
41.
KahnS.E., ZinmanB., LachinJ.M.Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT).Diabetes Care2008; 31: 845–51.
42.
SchwartzA.V., SellmeyerD.E., VittinghoffE.Thiazolidinedione use and bone loss in older diabetic adults.J Clin Endocrinol Metab2006; 91: 3349–54.
43.
YaturuS., BryantB., JainS.K.. Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men.Diabetes Care2007; 30: 1574–6.
44.
MeierC., KraenzlinM.E., BodmerM., JickS.S., JickH., MeierC.R.. Use of thiazolidinediones and fracture risk.Arch Intern Med2008; 168: 820–5.
45.
Lecka-CzernikB., MoermanE.J., GrantD.F., LehmannJ.M., ManolagasS.C., JilkaR.L.. Divergent effects of selective peroxisome proliferator–activated receptor-gamma 2 ligands on adipocyte versus osteoblast differentiation.Endocrinology2002; 143: 2376–84.
46.
AliA.A., WeinsteinR.S., StewartS.A., ParfittA.M., ManolagasS.C., JilkaR.L.. Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation.Endocrinology2005; 146: 1226–35.
47.
Product information.Avandia (rosiglitazone).Research Triangle Park, NC: GlaxoSmithKline, 2008.
